Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-25

Clinical Trial Update: Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the fixed-dose combination of perindopril, indapamide, and amlodipine for hypertension reports efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perindopril/Indapamide/Amlodipine fixed-dose combination (perindopril/indapamide/amlodipine)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Hypertension | Phase 3 | Status: COMPLETED